Wound Care Product Manufacturing in European Union 2026: Industry Statistics & Trends

The European Union wound care manufacturing sector encompasses the production of advanced dressings, sutures, and specialized medical textiles designed to manage acute and chronic wounds. The industry is characterized by high innovation in active healing technologies and steady expansion, supported by a total EU medical device market turnover estimated at approximately €160 billion in 2023 (MedTech Europe). Driven by an aging demographic and rising incidence of lifestyle-related chronic ulcers, manufacturers are increasingly pivoting toward digitalized 'smart' wound care solutions.

Industry snapshot

Key public data points

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Wound Care Product Manufacturing in European Union industry cover?

This industry covers the manufacturing of medical devices used for wound treatment, ranging from basic absorbent materials to advanced bioactive dressings that promote tissue regeneration. It includes surgical staples, sutures, ligatures, and sterile adhesive dressings classified under medical supplies.

• •Primary classification falls under NACE Rev. 2 code 32.50: Manufacture of medical and dental instruments and supplies.
• •Scope includes collagen-based dressings, hydrogels, alginates, and negative pressure wound therapy (NPWT) systems.
• •Excludes general hospital furniture and non-sterile basic textile production.

Who operates in the industry and how is it structured?

The European market is a mix of large-scale multinational corporations with centralized R&D hubs and specialized SMEs focusing on niche material science. Germany, France, and Switzerland serve as major production centers, benefiting from established pharmaceutical and chemical supply chains.

• •MedTech Europe represents over 33,000 companies in the broader medical technology sector, a significant portion of which are active in wound management.
• •Over 95% of companies in the European medical technology sector are Small and Medium-sized Enterprises (SMEs).
• •High concentration of production capacity exists in the DACH region (Germany, Austria, Switzerland).

What drives demand in the industry?

Demand is intrinsically linked to the prevalence of chronic conditions, such as diabetes and vascular diseases, which frequently lead to non-healing wounds. Additionally, the increasing focus on reducing hospital stays through efficient home-care wound management solutions is shifting production priorities toward user-friendly, self-applicable products.

• •Increasing prevalence of diabetes across the EU, affecting over 32 million adults, drives chronic ulcer treatment demand.
• •Aging population demographics increase the frequency of pressure ulcers and surgical site complications.
• •Public health initiatives prioritizing cost-effective 'value-based' healthcare delivery.

Who are the notable companies in the industry?

The landscape is highly competitive, dominated by major global players with deep integration in European healthcare procurement systems. These companies compete on intellectual property portfolios related to infection control and advanced moisture-balancing materials.

• •B. Braun Melsungen AG (Germany): A leader in surgical sutures and wound closure systems.
• •Paul Hartmann AG (Germany): Specializes in professional wound care and compression therapy.
• •Coloplast A/S (Denmark): Focuses on wound and skin care alongside ostomy products.
• •Smith & Nephew plc (UK/International): Major provider of advanced wound management solutions and NPWT.

How is the industry regulated?

Manufacturers must adhere to the European Medical Devices Regulation (MDR) 2017/745, which mandates rigorous clinical evidence and post-market surveillance. Compliance has become a significant barrier to entry, requiring heavy investment in technical documentation and notified body audits.

• •Transition to MDR 2017/745 requires CE marking certification for all devices sold in the EEA.
• •ISO 13485:2016 remains the global standard for quality management systems required by EU manufacturers.
• •EUDAMED database implementation increases transparency for device traceability and clinical safety.

Government, statistical and trade sources used for this Claight analysis.

• MedTech Europe 'The European Medical Technology Industry in Figures 2024' ·
• European Commission Public Health - Medical Devices Regulations (MDR) ·
• International Diabetes Federation (IDF) Diabetes Atlas 2022-2023 ·
• Eurostat NACE Rev. 2 Statistical Classification ·
• Company Annual Reports (B. Braun, Coloplast, Smith & Nephew)